A natural product from Abies sachalinensis has been shown to be potent against HCC cells and can improve the therapeutic effect of low-dose sorafenib by increasing the number of intratumoral CD8+ T cells and enhancing tumor cell death [187]. The gene discussed is CD8A; the disease is neoplasm.